Market
Agilent acquires Proscia in deal worth up to $270m
Agilent Technologies has agreed to acquire Proscia for up to $270 million, with closing expected in fiscal 2027. The deal follows Agilent's $950 million purchase of Biocare Medical in March 2026, continuing the company's expansion in pathology and digital diagnostics.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network